Interleukin 2: a review

Arzneimittelforschung. 1985;35(10):1607-15.

Abstract

Interleukin 2 (IL 2) is a central mediator of the growth and functional activity of B- and T-cells, and cytotoxic cells, including Natural Killer and Lymphokine Activated Killer cells. Significant defects in the production of, and response to, IL 2 have been described in a variety of congenital and acquired immunodeficiency states. IL 2 has demonstrated major anti-tumor activity in animal models. The biochemistry and molecular biology of IL 2 and its gene are reviewed, along with data regarding the IL 2 receptor, normal T-cell activation, abnormalities in IL 2 production and response in immunodeficiency states and leukemia, and initial explorations of IL 2 in the treatment of human cancer.

Publication types

  • Review

MeSH terms

  • Acquired Immunodeficiency Syndrome / immunology
  • Acquired Immunodeficiency Syndrome / therapy
  • Amino Acid Sequence
  • Animals
  • Antibodies, Monoclonal
  • Clone Cells
  • DNA Restriction Enzymes
  • Humans
  • Interleukin-2 / immunology
  • Interleukin-2 / metabolism
  • Interleukin-2 / pharmacology
  • Interleukin-2 / physiology*
  • Interleukin-2 / therapeutic use
  • Kinetics
  • Leukemia / immunology
  • Leukemia / therapy
  • Lymphocyte Activation / drug effects
  • Membrane Proteins / metabolism
  • Neoplasms / immunology
  • Neoplasms / therapy
  • Oligonucleotides / analysis
  • RNA, Messenger / metabolism
  • Receptors, Immunologic / metabolism
  • Receptors, Interleukin-2
  • T-Lymphocytes / immunology

Substances

  • Antibodies, Monoclonal
  • Interleukin-2
  • Membrane Proteins
  • Oligonucleotides
  • RNA, Messenger
  • Receptors, Immunologic
  • Receptors, Interleukin-2
  • DNA Restriction Enzymes